Advertisement

Topics

Companies Related to "Apomorphine Injection Parkinson Disease" [Most Relevant Company Matches] [Advanced Search Results] RSS

08:52 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Apomorphine Injection Parkinson Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Apomorphine Injection Parkinson Disease" Companies 1–25 of 2,700+

Relevant

Parkinson?s Unity Walk

Parkinson's disease is the second most common chronic neurological disorder in older adults after Alzheimer's, affecting approximately one percent of people over age 60. Approximately 15 percent of patients develop Parkinson's disease before the age of 50. Every nine minutes someone is diagnosed with Parkinson's disease. Symptoms include tremor, muscle rigidity, slowed motion, shuffling gait, and ...


Cynapsus Therapeutics Inc.

Cynapsus is a specialty pharmaceutical company developing a sublingual thin filmstrip for the acute rescue of OFF motor symptoms of Parkinson’s disease. Cynapsus’ drug candidate, APL-130277, is an easy-to-use, fast-acting formulation of apomorphine, which is the only approved drug (in the United States, Europe, Japan and other countries) to rescue ...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promising research to find the cause and cure for Parkinson's disease. Through the generous operational support of The Tuchman Foundation and our numerous partnerships, 100 percent of all individual donati...


APDA – Greater St. Louis

Every day, APDA – Greater St. Louis provides the support, education, and research that will help everyone impacted by Parkinson’s disease live life to the fullest. Located in Chesterfield, MO, APDA – Greater St. Louis funds the APDA Center for Advanced Parkinson Disease Research at Washington University School of Medicine. The Greater St. Louis Ch...

The Bachmann-Strauss Dystonia and Parkinson Foundation

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to provide medical and patient information. Lou Bachmann (1916-2000) and Bonnie Strauss founded The Bachmann-Strauss Dystonia & Parkinson Foundation (BSDPF) in 1995 as a nonprofit 5...

Brian Grant Foundation

Established in 2010, the Brian Grant Foundation supports efforts to build awareness and education of Parkinson's disease in order to increase earlier diagnosis, educate patients and their families, and provide a viable forum for people affected by Parkinson's. After playing professional basketball for 12 seasons in the NBA, Brian Grant was diagnosed in November of 2008 with young onset Parkinson's...

Medtronic and the Davis Phinney Foundation

The Davis Phinney Foundation's (DPF) mission is to improve the lives of those living with Parkinson's disease today by providing information and inspiration through research and programs. The foundation was established in 2004 by cycling legend Davis Phinney, who was diagnosed with Parkinson's disease at the age of 40. The foundation also works to communicate the importance of integrating exercise...

National Parkinson Foundation

Since 1982, NPF has funded more than $155 million in care, research, outreach and support services, addressing unmet needs at all stages of Parkinson's disease.

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

Amarantus Therapeutics, Inc.

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death, known as apoptosis, associated with a wide range of diseases, including but not limited to, neurodegenerative and cardiovascular. The Company’s most advanced drug candidate, AMRS00...

The Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The Foundation has funded almost $196 million in research to date.

Global Kinetics Corporation

Global Kinetics Corporation (GKC) is a privately held technology company headquartered in Australia focused on globally commercialising its innovative movement disorder technology, specifically for the treatment of Parkinson’s Disease. The company’s lead product is the Parkinson’s KinetiGraph (PKG), a first in class medical technology enabling ...

HollyRod Foundation

The HollyRod Foundation is dedicated to providing medical, physical and emotional support to those living with Autism and Parkinson's disease. Efforts of the HollyRod Foundation are providing a better quality of life for individuals and their families. HollyRod was inspired Holly's father's battle with Parkinson's Disease. After their eldest son RJ's diagnosis, the Peete's added Autism to their ...

The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed

The Silverstein Foundation is a 501(c)(3) non-profit organization founded in 2017 focused on investing in cutting edge research with the goal of discovering new therapies for the treatment of Parkinson's Disease in glucocerebrosidase (GBA1) mutation carriers. For more information, please visit www.silversteinfoundation.org.

CNS Therapeutics

Founded in 2007 by recognized experts in intrathecal drug therapies, CNS Therapeutics is a private company based in St. Paul, Minnesota. CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain. In addition to this first FDA-approved pr...

NeoTherapeutics Incorporated

NeoTherapeutics Incorporated is a development stage biopharmaceutical company engaged in the discovery and development of novel therapeutic drugs intended to treat neurodegenerative diseases and conditions, such as memory deficits associated with Alzheimer's disease and aging, stroke, spinal cord injuries, Parkinson's disease, migraine, depression and obesity. The Company's initial product candida...

Newron Pharmaceuticals S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain. The Company is headquartered in Bresso near Milan, Italy. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patie...

Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within the coming decade through an aggressively funded research agenda. The Foundation has funded almost $196 million in research to date.

Neurome, Inc

Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases. The company focuses its efforts on Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) - usually fatal neurodegenerative disorders that are currently untreatable and share characteristics which mak...

Amorfix Life Sciences Ltd.

The Aggregated Misfolded Protein diseases include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).

American Parkinson Disease Association

Prexton Therapeutics

Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson’s disease and other brain disorders. Prexton Therapeutics has the expertise to design novel mGluR4 compounds as new treatment for Parkinson’s disease. One of the major objectives of research into new treatments for Parkinson’s disease is to find ...

Neurology Medical Group of Diablo Valley

For over 30 years, the physicians at Neurology Medical Group of Diablo Valley have provided care for patients with disorders of the nervous system in the East Bay/Contra Costa region of San Francisco Bay Area. Three offices are available for appointment at locations in Concord, Walnut Creek, and Danville. We are dedicated to the ideal of optimum patient care via proper diagnosis, treatment, and go...

Amarantus BioScience, Inc.

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson’s disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Co...

Lantheus Medical Imaging, Inc.

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medicine for more than 50 years, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The company’s proven success in discovering, developing and marketing innovative medical imaging agents provides a strong platform fr...


More From BioPortfolio on "Apomorphine Injection Parkinson Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks